Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −6 vs. Q1 2021
- Shares held
- 2.32M
- −831.7K (−26.4%) vs. Q1 2021
- Total value
- $22.7M
- −$23.1M (−50.5%) vs. Q1 2021
- New holders
- 3
- 14 more added
- Sold out
- 9
- 13 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 387,753 | $3.78M | 0.00% | +63,057+19.4% | Added |
| BlackRock Inc. | 363,466 | $3.55M | 0.00% | +30,766+9.2% | Added |
| Citadel Advisors LLC | 283,667 | $2.77M | 0.00% | −408,870−59.0% | Reduced |
| JPMorgan Chase & Co | 179,078 | $1.75M | 0.00% | +23,431+15.1% | Added |
| Geode Capital Management, LLC | 141,809 | $1.38M | 0.00% | +24,403+20.8% | Added |
| Moore Capital Management, LP | 127,500 | $1.24M | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 107,726 | $1.05M | 0.00% | +101,151+1,538.4% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $976.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 100,000 | $976.0K | 0.00% | +41,229+70.2% | Added |
| Formula Growth Ltd | 100,000 | $976.0K | 0.13% | +43,724+77.7% | Added |
| Northern Trust Corp | 75,011 | $733.0K | 0.00% | −6,936−8.5% | Reduced |
| Charles Schwab Investment Management Inc | 54,965 | $537.0K | 0.00% | +8,720+18.9% | Added |
| Zimmer Partners, LP | 46,000 | $449.0K | 0.01% | 00.0% | Unchanged |
| Alps Advisors Inc | 40,286 | $393.0K | 0.00% | +40,286 | New |
| Alyeska Investment Group, L.P. | 40,000 | $390.0K | 0.00% | +40,000 | New |
| Tudor Investment Corp Et Al | 28,111 | $274.0K | 0.01% | −85,242−75.2% | Reduced |
| Two Sigma Advisers, LP | 23,200 | $226.0K | 0.00% | +12,200+110.9% | Added |
| Pura Vida Investments, LLC | 22,603 | $208.0K | 0.01% | −44,754−66.4% | Reduced |
| Two Sigma Investments, LP | 18,551 | $181.0K | 0.00% | −27,561−59.8% | Reduced |
| Bank of New York Mellon Corp | 18,431 | $180.0K | 0.00% | +4,369+31.1% | Added |
| Nuveen Asset Management, LLC | 12,536 | $122.0K | 0.00% | +196+1.6% | Added |
| Bank of America Corp | 11,675 | $115.0K | 0.00% | −2,288−16.4% | Reduced |
| Wells Fargo & Company | 11,081 | $108.0K | 0.00% | +8,701+365.6% | Added |
| California State Teachers Retirement System | 10,529 | $103.0K | 0.00% | −965−8.4% | Reduced |
| New York State Common Retirement Fund | 5,396 | $53.0K | 0.00% | +1,462+37.2% | Added |
| Deutsche Bank AG | 4,653 | $45.0K | 0.00% | −12,779−73.3% | Reduced |
| American International Group, Inc. | 4,266 | $42.0K | 0.00% | −175−3.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,410 | $14.0K | 0.00% | +840+147.4% | Added |
| UBS Group AG | 694 | $7.00K | 0.00% | −1,405−66.9% | Reduced |
| Royal Bank of Canada | 679 | $7.00K | 0.00% | −56−7.6% | Reduced |
| Legal & General Group Plc | 593 | $6.00K | 0.00% | −124−17.3% | Reduced |
| Ameritas Investment Partners, Inc. | 620 | $6.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 362 | $4.00K | 0.00% | −145−28.6% | Reduced |
| Banque Cantonale Vaudoise | 300 | $3.00K | 0.00% | +300 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −213,658−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −27,603−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Serengeti Asset Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −18,273−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,629−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −270−100.0% | Sold out |